Canada Life’s Stemline Therapeutics, Inc. STML Stock Holding History

Canada Life’s Portfolio STML Stock Details STML Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-2,733	Closed	-$13K	–	2842
2020 Q1	$13K	Hold	2,733	–	–	﹤0.01%	2469
2019 Q4	$29K	Buy	+2,733	New	+$27.1K	﹤0.01%	2424
2019 Q3	–	Sell	-5,150	Closed	-$79K	–	2654
2019 Q2	$79K	Hold	5,150	–	–	﹤0.01%	2301
2019 Q1	$66K	Hold	5,150	–	–	﹤0.01%	2193
2018 Q4	$47K	Buy	+5,150	New	+$66.8K	﹤0.01%	2398
2015 Q3	–	Sell	-25,200	Closed	-$297K	–	2618
2015 Q2	$297K	Buy	25,200 +12,700	+102%	+$176K	﹤0.01%	1173
2015 Q1	$180K	Sell	12,500 -400	-3%	-$6.12K	﹤0.01%	1402
2014 Q4	$220K	Buy	+12,900	New	+$186K	﹤0.01%	1260

Canada Life's STML Position: Q2 2020 in Review

Canada Life sold out of Stemline Therapeutics, Inc. (STML) in Q2 2020, closing a stake of 2,733 shares — an estimated $13K sold.

Canada Life first reported a position in STML in Q4 2014 and held it in 8 quarters. The position peaked at $297K in Q2 2015. 0 funds tracked by Wall St. Rank hold STML as of Q2 2020.

Canada Life reported no remaining Stemline Therapeutics, Inc. position as of Q2 2020 after selling out during the quarter.
Canada Life sold 2,733 Stemline Therapeutics, Inc. shares in Q2 2020, an estimated $13K.
Canada Life first reported a position in Stemline Therapeutics, Inc. in Q4 2014 and held it in 8 quarters.
Canada Life's Stemline Therapeutics, Inc. position peaked at $297K in Q2 2015.
0 funds tracked by Wall St. Rank held Stemline Therapeutics, Inc. as of Q2 2020.

Based on Canada Life's 13F filing for Q2 2020, filed 17 Aug 2020.